Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-rare
/
Ultragenyx Pharmaceutical Inc
RARE
Add to Watchlist
32.870
USD
-0.520
-1.56%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
3.23B
Market Cap
Loss
P/E TTM
Ultragenyx Pharmaceutical Inc
32.870
-0.520
-1.56%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Vanguard Portfolio Management, LLC
5.47%
BlackRock Institutional Trust Company, N.A.
5.47%
State Street Investment Management (US)
5.10%
Vanguard Capital Management, LLC
4.25%
Sands Capital Management, LLC
3.26%
Other
76.45%
Shareholders
Shareholders
Proportion
Vanguard Portfolio Management, LLC
5.47%
BlackRock Institutional Trust Company, N.A.
5.47%
State Street Investment Management (US)
5.10%
Vanguard Capital Management, LLC
4.25%
Sands Capital Management, LLC
3.26%
Other
76.45%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.10%
Investment Advisor/Hedge Fund
25.80%
Hedge Fund
17.03%
Research Firm
4.75%
Individual Investor
3.79%
Sovereign Wealth Fund
1.28%
Venture Capital
0.51%
Pension Fund
0.44%
Bank and Trust
0.40%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
695
106.19M
107.82%
-1.32M
2025Q4
665
100.29M
103.96%
-2.21M
2025Q3
640
97.34M
100.90%
-3.53M
2025Q2
635
97.48M
101.32%
-2.63M
2025Q1
652
96.83M
102.45%
-3.19M
2024Q4
645
94.29M
102.32%
-4.54M
2024Q3
633
93.51M
101.49%
-6.93M
2024Q2
618
95.17M
101.90%
+3.05M
2024Q1
605
86.17M
101.67%
-4.74M
2023Q4
588
86.44M
105.27%
+5.64M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.07M
5.26%
+54.55K
+1.09%
Sep 30, 2025
State Street Investment Management (US)
3.69M
3.83%
+1.12M
+43.55%
Sep 30, 2025
Sands Capital Management, LLC
3.77M
3.91%
-173.63K
-4.40%
Sep 30, 2025
JP Morgan Asset Management
3.25M
3.37%
+644.31K
+24.74%
Sep 30, 2025
RTW Investments L.P.
3.26M
3.38%
+1.55M
+90.83%
Sep 30, 2025
Kakkis (Emil D)
2.69M
2.79%
-31.78K
-1.17%
Mar 07, 2025
Baker Bros. Advisors LP
2.77M
2.87%
--
--
Sep 30, 2025
Wellington Management Company, LLP
1.95M
2.02%
+73.31K
+3.92%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Motley Fool Small-Cap Growth ETF
3.73%
Global X Genomics & Biotechnology ETF
3.19%
Franklin Genomic Advancements ETF
1.59%
Virtus LifeSci Biotech Products ETF
1.41%
State Street SPDR S&P Biotech ETF
1.32%
WisdomTree BioRevolution Fund
0.94%
Direxion Daily S&P Biotech Bull 3X Shares
0.81%
Touchstone Sands Capital US Select Growth ETF
0.8%
Goldman Sachs Future Health Care Equity ETF
0.6%
First Trust Multi-Manager Large Growth ETF
0.54%
View more
Motley Fool Small-Cap Growth ETF
Proportion
3.73%
Global X Genomics & Biotechnology ETF
Proportion
3.19%
Franklin Genomic Advancements ETF
Proportion
1.59%
Virtus LifeSci Biotech Products ETF
Proportion
1.41%
State Street SPDR S&P Biotech ETF
Proportion
1.32%
WisdomTree BioRevolution Fund
Proportion
0.94%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.81%
Touchstone Sands Capital US Select Growth ETF
Proportion
0.8%
Goldman Sachs Future Health Care Equity ETF
Proportion
0.6%
First Trust Multi-Manager Large Growth ETF
Proportion
0.54%